SCHEMBL10092811

SCHEMBL10092811

CCc1ccccc1OC(C)CC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 2/20 0.49
ADRA2B P18089 2/20 0.49
ADRA2C P18825 2/20 0.49
L3MBTL1 Q9Y468 4/20 0.47
MAPT P10636 3/20 0.47
NPSR1 Q6W5P4 1/20 0.47
MCHR1 Q99705 1/20 0.45
HPGD P15428 1/20 0.41
ATM Q13315 1/20 0.41
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 1/20 0.38
KDM4E B2RXH2 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31490284 0.85 MCHR1 (0.51) ADRA2AADRA2BADRA2CMAPTMCHR1
SCHEMBL7013166 0.85 MCHR1 (0.46) ADRA2AADRA2BADRA2CMAPTMCHR1
SCHEMBL20739977 0.85 MCHR1 (0.43) ADRA2AADRA2BADRA2CL3MBTL1MAPT
SCHEMBL22513126 0.85 MCHR1 (0.48) ADRA2AADRA2BADRA2CL3MBTL1MAPT
SCHEMBL12301968 0.85 ADRA2A (0.47) ADRA2AADRA2BADRA2CL3MBTL1MAPT
SCHEMBL15118684 0.85 MCHR1 (0.43) ADRA2AADRA2BADRA2CL3MBTL1MAPT
SCHEMBL5412735 0.83 ADRA2A (0.51) ADRA2AADRA2BADRA2CL3MBTL1MAPT
SCHEMBL22512822 0.83 L3MBTL1 (0.47) ADRA2AADRA2BADRA2CL3MBTL1MAPT
SCHEMBL24200105 0.83 CXCL8 (0.50) L3MBTL1MAPTMTNR1AMTNR1B
SCHEMBL8086435 0.83 CXCL8 (0.50) L3MBTL1MAPTMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598517-B1 MODULATORS OF PROTEASE ACTIVATED RECEPTORS UNIV QUEENSLAND (AU) 2019-06-26 EP disclosed
US-9868763-B2 Modulators of protease activated receptors THE UNIVERSITY OF QUEENSLAND (AU) 2018-01-16 US disclosed
US-9701711-B2 Modulators of protease activated receptors THE UNIVERSITY OF QUEENSLAND (AU) 2017-07-11 US disclosed
US-20150038402-A1 MODULATORS OF PROTEASE ACTIVATED RECEPTORS UNIV QUEENSLAND (AU) 2015-02-05 US disclosed
US-8927503-B2 Modulations of protease activated receptors THE UNIVERSITY OF QUEENSLAND (AU) 2015-01-06 US disclosed
US-8901085-B2 2014-12-02 US disclosed
US-20140315796-A1 MODULATORS OF PROTEASE ACTIVATED RECEPTORS THE UNIVERSITY OF QUEENSLAND (AU) 2014-10-23 US disclosed
US-20130184226-A1 MODULATIONS OF PROTEASE ACTIVATED RECEPTORS THE UNIVERSITY OF QUEENSLAND (AU) 2013-07-18 US disclosed
WO-2012012843-A1 MODULATORS OF PROTEASE ACTIVATED RECEPTORS THE UNIVERSITY OF QUEENSLAND (AU) 2012-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130184226-A1 MODULATIONS OF PROTEASE ACTIVATED RECEPTORS F2R, F2RL1, F2RL3 ADRA2A 611/4885ADRA2B 696/4885ADRA2C 661/4885
US-20140315796-A1 MODULATORS OF PROTEASE ACTIVATED RECEPTORS F2R, F2RL1, F2RL3 ADRA2A 815/4885ADRA2B 670/4885ADRA2C 975/4885
US-20150038402-A1 MODULATORS OF PROTEASE ACTIVATED RECEPTORS F2R, F2RL1, F2RL3 ADRA2A 531/4885ADRA2B 517/4885ADRA2C 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.